Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a
P Soulié, P Ruffié, L Trandafir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors
A Taamma, J L Misset, M Riofrio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases
E Cvitkovic, M Bachouchi, H Boussen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study
C Louvet, T André, G Lledo, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients
P Soulié, C Garrino, M A Bensmaïne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
N Azli, J P Armand, M Rahal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer
P Soulié, A Bensmaïne, C Garrino, et al.
Journal of the National Cancer Institute
|
April 4, 1990
High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
M Bachouchi, E Cvitkovic, N Azli, et al.
The Cancer Journal From Scientific American
|
October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type
N Azli, A Fandi, M Bachouchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type
A Fandi, M Bachouchi, N Azli, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a
P Soulié, P Ruffié, L Trandafir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors
A Taamma, J L Misset, M Riofrio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases
E Cvitkovic, M Bachouchi, H Boussen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study
C Louvet, T André, G Lledo, et al.
Journal of Cancer Research and Clinical Oncology
|
December 11, 1999
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients
P Soulié, C Garrino, M A Bensmaïne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type
N Azli, J P Armand, M Rahal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer
P Soulié, A Bensmaïne, C Garrino, et al.
Journal of the National Cancer Institute
|
April 4, 1990
High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
M Bachouchi, E Cvitkovic, N Azli, et al.
The Cancer Journal From Scientific American
|
October 1, 1995
Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type
N Azli, A Fandi, M Bachouchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type
A Fandi, M Bachouchi, N Azli, et al.
Page
of 13